Balance Sheet Data

Novartis AG (NVS)

$87.71

+0.42 (+0.48%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 9,48515,96411,44611,29328,11315,917.3116,159.2916,404.9416,654.3416,907.52
Total Cash (%)
Account Receivables 11,10011,02410,33710,0369,62110,995.9111,163.0711,332.7711,505.0511,679.95
Account Receivables (%)
Inventories 6,8676,9565,9827,2426,6667,106.277,214.307,323.977,435.317,548.34
Inventories (%)
Accounts Payable 5,1695,5565,4245,4035,5535,715.205,802.085,890.285,979.836,070.74
Accounts Payable (%)
Capital Expenditure -2,746-3,355-2,257-2,585-2,971-2,922.77-2,967.20-3,012.31-3,058.10-3,104.59
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.